Stay updated with breaking news from Teva pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Teva®, a division of Deckers Brands (NYSE: DECK), is excited to announce the launch of the Keep Rivers Wild Capsule Collection in collaboration. ....
Morgan Stanley assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Get Rating) in a research note issued to investors on Thursday morning, The Fly reports. The firm issued an equal weight rating and a $10.00 price objective on the stock. A number of other research firms have also recently commented on TEVA. Evercore […] ....
Phoenix Holdings Ltd. raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) by 6.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 22,158,551 shares of the company’s stock after purchasing an additional 1,327,471 shares during […] ....
But there s another story here that the journal actually had in an editorial earlier in the week that s very profound which is about generics. generic companies like teva in israel, they cherry pick where they re going to make their drugs. they re not going to compete with 14 other companies with a narrow profit margin. they say we want that one because there s only one or two other companies competing with us. so drugs like chemotherapy are on a very narrow profit margin. so if you have a shutdown factory because of a violation, let s say because of, you know, they have to relook at a factory because there was some kind of contamination or you don t have the supply, you don t have the active pharmaceutical ingredients or the demand goes up because people waited during the pandemic to get their chemo, i m faced with having to tell people with cancer to wait for their treatment or get different chemotherapy than they were supposed to get. it s a huge, huge crisis that s going on. charle ....
Teva in israel is not going to compete with 15 other companies. they look for a market that they can control. and if the government isn t paying enough, hello, welcome to that. listen to our government. medicare and medicaid paying less and less for these drugs tgenerics are not going to produce them and then the government starts regulating. look at the inflation reduction act saying if you raise prices faster than inflation you have to give a rebate. guess who gets the rebate? not the patient, not the hospital. it s the middleman, the middleman that s putting it all together just to make sure that the drugs get into the hospital. all of that going on leads to a shortage. and you know what that means for a doctor like me? it means i can t prescribe the life-saving drug i need. i ve got to delay treatment for things like cancer, for intravenous for life threatening asthma. let me give you one specific example you re going to be amazed at. bladder cancer. for bladder cancer we use a ....